These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2898903)

  • 21. Pharmacogenetics of N-methylation: heritability of human erythrocyte histamine N-methyltransferase activity.
    Scott MC; Van Loon JA; Weinshilboum RM
    Clin Pharmacol Ther; 1988 Mar; 43(3):256-62. PubMed ID: 3345617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain.
    Hough LB; Jackowski S; Eberle N; Gogas KR; Camarota NA; Cue D
    Biochem Pharmacol; 1988 Dec; 37(24):4707-11. PubMed ID: 3202904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of histamine-N-methyltransferase and histaminase (diamine oxidase) by a new histamine H2-receptor agonist, Dimaprit.
    Shaff RE; Beaven MA
    Biochem Pharmacol; 1977 Nov; 26(21):2075-8. PubMed ID: 411497
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of histamine metabolism in vitro and in vivo. Correlations with antitrypanosomal activity.
    Duch DS; Bacchi CJ; Edelstein MP; Nichol CA
    Biochem Pharmacol; 1984 May; 33(9):1547-53. PubMed ID: 6428421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular identification of carnosine N-methyltransferase as chicken histamine N-methyltransferase-like protein (hnmt-like).
    Drozak J; Chrobok L; Poleszak O; Jagielski AK; Derlacz R
    PLoS One; 2013; 8(5):e64805. PubMed ID: 23705015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine H2-receptor antagonists inhibit enzymic histamine degradation in human skin.
    Corbett R; Greaves MW
    Clin Exp Dermatol; 1979 Mar; 4(1):99-102. PubMed ID: 445880
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac and regional haemodynamic effects of histamine N-methyltransferase inhibitor metoprine in haemorrhage-shocked rats.
    Jochem J
    Inflamm Res; 2004 Jul; 53(7):316-23. PubMed ID: 15241567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural features of potent inhibitors of rat kidney histamine N-methyltransferase.
    Harle DG; Baldo BA
    Biochem Pharmacol; 1988 Feb; 37(3):385-8. PubMed ID: 3337739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impromidine, a potent inhibitor of histamine methyltransferase (HMT) and diamine oxidase (DAO).
    Beaven MA; Roderick NB
    Biochem Pharmacol; 1980 Oct; 29(20):2897-900. PubMed ID: 6449204
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of amodiaquine on histamine level and histamine-methyltransferase activity in the rat brain.
    Nowak JZ; Zandarowska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(6):927-30. PubMed ID: 6789797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interindividual variability of histamine N-methyltransferase in the human liver and kidney.
    De Santi C; Donatelli P; Giulianotti PC; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 1998 Jun; 28(6):571-7. PubMed ID: 9667080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Product inhibition of rat brain histamine-N-methyltransferase.
    Orr EL; Quay WB
    J Neurochem; 1978 Jun; 30(6):1539-42. PubMed ID: 670996
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence for a role of endogenous histamine in central cardiovascular regulation: inhibition of histamine-N-methyltransferase by SKF 91488.
    Klein MC; Gertner SB
    J Pharmacol Exp Ther; 1981 Feb; 216(2):315-20. PubMed ID: 6450831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
    Girard B; Otterness DM; Wood TC; Honchel R; Wieben ED; Weinshilboum RM
    Mol Pharmacol; 1994 Mar; 45(3):461-8. PubMed ID: 8145732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of drugs on the activity of histamine-N-methyltransferase from guinea pig skin.
    Tachibana T; Taniguchi S; Imamura S; Fujiwara M; Hayashi H
    Biochem Pharmacol; 1988 Jul; 37(14):2872-6. PubMed ID: 2899431
    [No Abstract]   [Full Text] [Related]  

  • 36. New inhibitors of histamine-N-methyltransferase.
    Beaven MA; Shaff RE
    Biochem Pharmacol; 1979; 28(2):183-8. PubMed ID: 34400
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural basis for inhibition of histamine N-methyltransferase by diverse drugs.
    Horton JR; Sawada K; Nishibori M; Cheng X
    J Mol Biol; 2005 Oct; 353(2):334-344. PubMed ID: 16168438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) inhibitors.
    Zawilska J; Nowak JZ
    Pol J Pharmacol Pharm; 1985; 37(6):821-30. PubMed ID: 3832018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase.
    Nishibori M; Oishi R; Itoh Y; Saeki K
    Jpn J Pharmacol; 1991 Apr; 55(4):539-46. PubMed ID: 1886293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease.
    Reich DL; Mulier J; Viby-Mogensen J; Konstadt SN; van Aken HK; Jensen FS; DePerio M; Buckley SG
    Can J Anaesth; 1998 Aug; 45(8):794-7. PubMed ID: 9793671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.